Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,760
-590 (-4.11%)
At close: Jul 4, 2025, 3:30 PM KST
15.73%
Market Cap 737.11B
Revenue (ttm) 222.50B
Net Income (ttm) -13.49B
Shares Out 51.26M
EPS (ttm) -263.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 337,720
Average Volume 1,276,167
Open 14,350
Previous Close 14,350
Day's Range 13,670 - 14,760
52-Week Range 6,400 - 20,500
Beta 2.20
RSI 54.27
Earnings Date Aug 14, 2025

About KRX:019170

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun... [Read more]

Sector Healthcare
Founded 1962
Employees 819
Stock Exchange Korea Stock Exchange
Ticker Symbol 019170
Full Company Profile

Financial Performance

In 2024, KRX:019170's revenue was 221.09 billion, an increase of 10.42% compared to the previous year's 200.23 billion. Losses were -14.82 billion, -74.15% less than in 2023.

Financial Statements

News

There is no news available yet.